Literature DB >> 22398680

Myocardial involvement in patients with osteogenesis imperfecta.

Katsura Soma1, Hajime Abe, Norihiko Takeda, Yukako Shintani, Yutaka Takazawa, Toshiya Kojima, Katsuhito Fujiu, Hiroaki Semba, Hiroshi Yamashita, Yasunobu Hirata, Masashi Fukayama, Ryozo Nagai.   

Abstract

Mitral and aortic valve regurgitation is commonly found in osteogenesis imperfecta (OI) patients, however, little is known about the myocardial involvement in this disorder. An 82-year-old man with OI developed heart failure and was admitted to our hospital. Echocardiogram revealed severe mitral regurgitation without left ventricular (LV) dilatation, but with LV wall thickening. Histological analysis exhibited interstitial fibrosis of the myocardium in addition to myxoid changes of the mitral leaflet. These findings suggest that OI patients may develop LV remodeling together with diastolic dysfunction.

Entities:  

Mesh:

Year:  2012        PMID: 22398680     DOI: 10.1536/ihj.53.75

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  3 in total

1.  Echocardiographic Evidence of Early Diastolic Dysfunction in Asymptomatic Children with Osteogenesis Imperfecta.

Authors:  Khalfan S Al-Senaidi; Irfan Ullah; Hashim Javad; Murtadha Al-Khabori; Saif Al-Yaarubi
Journal:  Sultan Qaboos Univ Med J       Date:  2015-11-23

2.  Cytoskeleton and nuclear lamina affection in recessive osteogenesis imperfecta: A functional proteomics perspective.

Authors:  Assunta Gagliardi; Roberta Besio; Chiara Carnemolla; Claudia Landi; Alessandro Armini; Mona Aglan; Ghada Otaify; Samia A Temtamy; Antonella Forlino; Luca Bini; Laura Bianchi
Journal:  J Proteomics       Date:  2017-08-09       Impact factor: 4.044

3.  Cardiovascular involvement in children with osteogenesis imperfecta.

Authors:  Hamdollah Karamifar; Homa Ilkhanipoor; Gholamhossein Ajami; Zohreh Karamizadeh; Gholamhossein Amirhakimi; Ali-Mohammad Shakiba
Journal:  Iran J Pediatr       Date:  2013-10       Impact factor: 0.364

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.